Reported 16 days ago
Abbott Laboratories reported a 7.1% increase in quarterly revenue, totaling $11.4 billion, thanks to strong demand for its medical devices, including continuous glucose monitors and heart devices. The company's third-quarter profit per share reached $1.30, matching analyst estimates, and it revised its annual profit predictions slightly upward. Sales in its medical devices segment surpassed expectations, contributing significantly to the overall growth.
Source: YAHOO